細胞増殖市場：製品、細胞タイプ、用途、エンドユーザー別-2025～2030年の世界予測

細胞増殖市場は、2023年に193億6,000万米ドルと評価され、2024年には209億米ドルに達すると予測され、CAGR 8.23％で成長し、2030年には337億米ドルになると予測されています。

細胞増殖は、バイオテクノロジーにおける重要なプロセスであり、主に研究、治療、産業用途のために、制御された環境下での細胞の成長と増殖を伴います。細胞増殖の必要性は、再生医療、組織工学、バイオ医薬品製造において重要な役割を果たすことから生じます。開発用途は、がん治療開発、幹細胞研究、ワクチン製造に及び、最終用途は、ラボ、臨床研究機関、バイオテクノロジー企業、製薬産業に及びます。

細胞増殖市場は、再生医療需要の増加、自動細胞培養技術の進歩、個別化医療の重視の高まりなどの要因によって牽引されています。世界人口の高齢化と慢性疾患の増加により、先進的細胞ベースの治療に対するニーズがさらに高まっています。さらに、3D細胞培養技術とバイオリアクターの台頭は、細胞増殖プロセスの効率性と拡大性を高める新たな機会を提示しています。しかし、この市場は、装置や試薬の高コスト、厳しい規制状況、幹細胞研究に関する倫理的懸念といった制約に直面しています。これらの課題は新技術の採用を妨げ、市場の成長を遅らせる可能性があります。

このセグメントでの技術革新と研究は、費用対効果に優れ、スケーラブルな拡大技術の開発、プロセス最適化のための人工知能の統合、培養システムの自動化を強化し、人的介入を減らすことに焦点を当てることができます。また、新規の生体材料やマイクロキャリア技術を探求することで、培養効率や生産物の質を高めることもできます。課題はあるもの、治療法の選択肢の改善を通じて医療に大きな影響を与える可能性を秘めた市場は、成長の態勢を整えています。企業にとっては、研究機関との協力関係を活用し、破壊的技術に投資し、規制の変化に対応することが、市場競争を確実にし、新たな機会を活用するための戦略的な動きとなります。市場のダイナミックな性質は、特に細胞培養技術の進歩と規制遵守の達成において、機敏さと先見性を要求します。

市場力学：急速に進化する細胞増殖市場の主要市場洞察を公開

細胞増殖市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 細胞培養技術の技術的進歩
  • 世界のがん、糖尿病、心血管疾患の罹患率の上昇
  • 幹細胞研究と再生医療における研究開発への継続的投資
• 市場抑制要因
  • 細胞増殖機器と消耗品の高コスト
• 市場機会
  • 細胞増殖用マイクロ流体デバイスの統合
  • 組織工学と再生医療に革命をもたらすバイオプリンティング技術の進歩
• 市場課題
  • 細胞ベースの治療法の承認に関する複雑な規制状況

ポーターのファイブフォース：細胞増殖市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞増殖市場における外部からの影響の把握

外部マクロ環境要因は、細胞増殖市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：細胞増殖市場における競合情勢の把握

細胞増殖市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：細胞増殖市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞増殖市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：細胞増殖市場における成功への道筋を描く

細胞増殖市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 細胞培養技術の技術的進歩
    • 世界中でがん、糖尿病、心血管疾患の発生率が上昇
    • 幹細胞研究と再生医療の研究開発への継続的な投資
  • 抑制要因
    • 細胞増殖機器や消耗品のコストが高い
  • 機会
    • 細胞増殖のマイクロ流体デバイスの統合
    • バイオプリンティング技術の進歩が組織工学と再生医療に革命をもたらす
  • 課題
    • 細胞ベースの治療法の承認に関する複雑な規制状況
• 市場セグメンテーション分析
  • 製品：調査やバイオ医薬品製造において不可欠な繰り返し使用のため、細胞増殖における消耗品の使用を拡大
  • 用途：再生医療と再生治療のための幹細胞研究における世界の拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 細胞増殖市場：製品別

• イントロダクション
• 消耗品
  • 使い捨て
  • 培地
  • 試薬
  • 血清
• 機器
  • 自動細胞増殖システム
  • バイオリアクター
    • マイクロキャリアバイオリアクター
    • 灌流型または中空糸型バイオリアクター
  • 細胞増殖サポート機器
    • 細胞カウンターと血球計数装置
    • 遠心分離機
    • フローサイトメーター

第7章 細胞増殖市場：細胞タイプ別

• イントロダクション
• 動物細胞
• ヒト細胞
  • 分化細胞
  • 幹細胞
    • 成体幹細胞
    • 胚性幹細胞
    • 誘導多能性幹細胞

第8章 細胞増殖市場：用途別

• イントロダクション
• がんと細胞ベースの研究
• 再生医療と幹細胞研究
• ワクチン製造

第9章 細胞増殖市場：エンドユーザー別

• イントロダクション
• バイオテクノロジーとバイオ医薬品企業
• 細胞バンク
• 研究機関

第10章 南北アメリカの細胞増殖市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の細胞増殖市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞増殖市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Thermo Fisher Scientificとマルチプライラボの戦略的提携、自動化による細胞治療製造の革命
  • luri、先進的細胞治療製造サービスのためのPluriCDMOを開始
  • Akadeum Life Sciencesが革新的な細胞分離と増殖キットで細胞治療研究を前進
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• Bio-Techne Corporation
• Celltainer BIoTech B.V.
• Corning Incorporated
• Cytiva
• Danaher Corporation
• Eppendorf SE
• G&G Technologies, Inc.
• GE Healthcare
• iXCells BIoTechnologies
• Lonza Group Ltd.
• Merck KGaA
• Miltenyi BIoTec B.V. & Co. KG
• Neuromics
• NexImmune
• Novartis AG
• PromoCell GmbH
• REPROCELL Inc.
• Sartorius AG
• Scinus Cell Expansion
• Stemcell Technologies, Inc.
• Takara Bio Inc.
• Terumo BCT
• TERUMO BCT, INC.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. CELL EXPANSION MARKET RESEARCH PROCESS
• FIGURE 2. CELL EXPANSION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CELL EXPANSION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL EXPANSION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL EXPANSION MARKET DYNAMICS
• TABLE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY SERA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY AUTOMATED CELL EXPANSION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL EXPANSION MARKET SIZE, BY MICROCARRIER BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL EXPANSION MARKET SIZE, BY PERFUSION OR HOLLOW FIBER BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL COUNTERS & HEMOCYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CELL EXPANSION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL EXPANSION MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL EXPANSION MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL EXPANSION MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL EXPANSION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CELL EXPANSION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL EXPANSION MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CELL EXPANSION MARKET SIZE, BY CANCER & CELL-BASED RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE & STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CELL EXPANSION MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL CELL EXPANSION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. CANADA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. CANADA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 77. CANADA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 80. CANADA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CANADA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 82. CANADA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 83. CANADA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. CANADA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. CHINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. CHINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. CHINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 130. CHINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 131. CHINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 132. CHINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. CHINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 134. CHINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 135. CHINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. CHINA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. INDIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. INDIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 139. INDIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. INDIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 141. INDIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 142. INDIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. INDIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 144. INDIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 145. INDIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. INDIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 153. INDONESIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 154. INDONESIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 155. INDONESIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. INDONESIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 163. JAPAN CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 164. JAPAN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 165. JAPAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. JAPAN CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 170. MALAYSIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 172. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. MALAYSIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 174. MALAYSIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 175. MALAYSIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. MALAYSIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 179. PHILIPPINES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 180. PHILIPPINES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 181. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 182. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 183. PHILIPPINES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 184. PHILIPPINES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 185. PHILIPPINES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. PHILIPPINES CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. SINGAPORE CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 189. SINGAPORE CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. SINGAPORE CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 191. SINGAPORE CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 192. SINGAPORE CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 193. SINGAPORE CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 194. SINGAPORE CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 195. SINGAPORE CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. SINGAPORE CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH KOREA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. TAIWAN CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. TAIWAN CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 209. TAIWAN CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 210. TAIWAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 211. TAIWAN CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 212. TAIWAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 213. TAIWAN CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 214. TAIWAN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 215. TAIWAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. TAIWAN CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. THAILAND CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. THAILAND CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. THAILAND CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. THAILAND CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 221. THAILAND CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 222. THAILAND CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 223. THAILAND CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 224. THAILAND CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 225. THAILAND CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. THAILAND CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. VIETNAM CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. VIETNAM CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 229. VIETNAM CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 230. VIETNAM CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 231. VIETNAM CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 232. VIETNAM CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 233. VIETNAM CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 234. VIETNAM CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 235. VIETNAM CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. VIETNAM CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 248. DENMARK CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 249. DENMARK CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 250. DENMARK CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 251. DENMARK CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 252. DENMARK CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 253. DENMARK CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 254. DENMARK CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 255. DENMARK CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 256. DENMARK CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. DENMARK CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 258. EGYPT CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. EGYPT CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 260. EGYPT CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 261. EGYPT CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 262. EGYPT CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 263. EGYPT CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 264. EGYPT CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 265. EGYPT CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 266. EGYPT CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. EGYPT CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. FINLAND CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. FINLAND CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 270. FINLAND CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 271. FINLAND CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 272. FINLAND CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 273. FINLAND CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 274. FINLAND CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 275. FINLAND CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 276. FINLAND CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. FINLAND CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 278. FRANCE CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 279. FRANCE CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 280. FRANCE CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 281. FRANCE CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 282. FRANCE CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 283. FRANCE CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 284. FRANCE CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 285. FRANCE CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 286. FRANCE CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. FRANCE CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. GERMANY CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 289. GERMANY CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 290. GERMANY CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 291. GERMANY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 292. GERMANY CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 293. GERMANY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 294. GERMANY CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 295. GERMANY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 296. GERMANY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 297. GERMANY CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 298. ISRAEL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. ISRAEL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 300. ISRAEL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 301. ISRAEL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 302. ISRAEL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 303. ISRAEL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 304. ISRAEL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 305. ISRAEL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 306. ISRAEL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. ISRAEL CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 308. ITALY CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 309. ITALY CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 310. ITALY CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 311. ITALY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 312. ITALY CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 313. ITALY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 314. ITALY CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 315. ITALY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 316. ITALY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. ITALY CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 318. NETHERLANDS CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. NETHERLANDS CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 320. NETHERLANDS CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 321. NETHERLANDS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 322. NETHERLANDS CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 323. NETHERLANDS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 324. NETHERLANDS CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 325. NETHERLANDS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 326. NETHERLANDS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 327. NETHERLANDS CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 328. NIGERIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 329. NIGERIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 330. NIGERIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 331. NIGERIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 332. NIGERIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 333. NIGERIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 334. NIGERIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 335. NIGERIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 336. NIGERIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 337. NIGERIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 338. NORWAY CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 339. NORWAY CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 340. NORWAY CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 341. NORWAY CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 342. NORWAY CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 343. NORWAY CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 344. NORWAY CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 345. NORWAY CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 346. NORWAY CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 347. NORWAY CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 348. POLAND CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 349. POLAND CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 350. POLAND CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 351. POLAND CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 352. POLAND CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 353. POLAND CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 354. POLAND CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 355. POLAND CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
• TABLE 356. POLAND CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 357. POLAND CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 358. QATAR CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 359. QATAR CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 360. QATAR CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 361. QATAR CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
• TABLE 362. QATAR CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 363. QATAR CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 364. QATAR CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 365. QATA

The Cell Expansion Market was valued at USD 19.36 billion in 2023, expected to reach USD 20.90 billion in 2024, and is projected to grow at a CAGR of 8.23%, to USD 33.70 billion by 2030.

Cell expansion is a critical process in biotechnology that involves the growth and proliferation of cells in a controlled environment, primarily for research, therapeutic, or industrial applications. The necessity for cell expansion arises from its vital role in regenerative medicine, tissue engineering, and biopharmaceutical manufacturing, all of which require large quantities of consistent and high-quality cell lines. Applications extend to cancer treatment development, stem cell research, and vaccine production, with end-use scope spanning laboratories, clinical research organizations, biotechnology companies, and pharmaceutical industries.

The market for cell expansion is driven by factors such as increasing demand for regenerative medicine, advancements in automated cell culture technologies, and a growing emphasis on personalized medicine. The aging global population and increased incidence of chronic diseases further underscore the need for advanced cell-based therapies. Additionally, the rise of 3D cell culture techniques and bioreactors presents new opportunities to enhance the efficiency and scalability of cell expansion processes. However, the market faces limitations like high costs of equipment and reagents, stringent regulatory landscapes, and ethical concerns regarding stem cell research. These challenges can hinder the adoption of new technologies and delay market growth.

Innovation and research in this field can focus on developing cost-effective and scalable expansion technologies, integrating artificial intelligence for process optimization, and enhancing the automation of culture systems to reduce human intervention. Exploring novel biomaterials and microcarrier technologies could also enhance culture efficiency and output quality. Despite the challenges, the market is poised for growth with the potential to significantly impact healthcare through improved therapeutic options. For businesses, capitalizing on collaborations with research institutions, investing in disruptive technologies, and staying attuned to regulatory changes are strategic moves to ensure market competitiveness and leverage emerging opportunities. The market's dynamic nature calls for agility and foresight, particularly in advancing cell culture techniques and achieving regulatory compliance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Expansion Market

The Cell Expansion Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Technological advancements in cell culture technologies
  • Rising incidence of cancer, diabetes, and cardiovascular diseases worldwide
  • Ongoing investments in R&D in stem cell research and regenerative medicine
• Market Restraints
  • High cost of cell expansion instruments and consumables
• Market Opportunities
  • Integration of microfluidic devices for cell expansion
  • Advancements in bioprinting technologies to revolutionize tissue engineering and regenerative medicine
• Market Challenges
  • Complex regulatory landscape for approval of cell-based therapies

Porter's Five Forces: A Strategic Tool for Navigating the Cell Expansion Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Expansion Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Expansion Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Expansion Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Expansion Market

A detailed market share analysis in the Cell Expansion Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Expansion Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Expansion Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Expansion Market

A strategic analysis of the Cell Expansion Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Expansion Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Techne Corporation, Celltainer Biotech B.V., Corning Incorporated, Cytiva, Danaher Corporation, Eppendorf SE, G&G Technologies, Inc., GE Healthcare, iXCells Biotechnologies, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Neuromics, NexImmune, Novartis AG, PromoCell GmbH, REPROCELL Inc., Sartorius AG, Scinus Cell Expansion, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, TERUMO BCT, INC., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Expansion Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Disposables, Media, Reagents, and Sera. The Instruments is further studied across Automated Cell Expansion System, Bioreactors, and Cell Expansion Supporting Equipment. The Bioreactors is further studied across Microcarrier Bioreactors and Perfusion or Hollow Fiber Bioreactors. The Cell Expansion Supporting Equipment is further studied across Cell Counters & Hemocytometers, Centrifuges, and Flow Cytometers.
• Based on Cell Type, market is studied across Animal Cells and Human Cells. The Human Cells is further studied across Differentiated Cells and Stem Cells. The Stem Cells is further studied across Adult Stem Cells, Embryonic Stem Cells, and Induced Pluripotent Stem Cells.
• Based on Application, market is studied across Cancer & Cell-Based Research, Regenerative Medicine & Stem Cell Research, and Vaccine Production.
• Based on End-User, market is studied across Biotechnology & Biopharmaceutical Companies, Cell Banks, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Technological advancements in cell culture technologies
    • 5.1.1.2. Rising incidence of cancer, diabetes, and cardiovascular diseases worldwide
    • 5.1.1.3. Ongoing investments in R&D in stem cell research and regenerative medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of cell expansion instruments and consumables
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of microfluidic devices for cell expansion
    • 5.1.3.2. Advancements in bioprinting technologies to revolutionize tissue engineering and regenerative medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Complex regulatory landscape for approval of cell-based therapies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production
  • 5.2.2. Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Expansion Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Disposables
  • 6.2.2. Media
  • 6.2.3. Reagents
  • 6.2.4. Sera
• 6.3. Instruments
  • 6.3.1. Automated Cell Expansion System
  • 6.3.2. Bioreactors
    • 6.3.2.1. Microcarrier Bioreactors
    • 6.3.2.2. Perfusion or Hollow Fiber Bioreactors
  • 6.3.3. Cell Expansion Supporting Equipment
    • 6.3.3.1. Cell Counters & Hemocytometers
    • 6.3.3.2. Centrifuges
    • 6.3.3.3. Flow Cytometers

7. Cell Expansion Market, by Cell Type

• 7.1. Introduction
• 7.2. Animal Cells
• 7.3. Human Cells
  • 7.3.1. Differentiated Cells
  • 7.3.2. Stem Cells
    • 7.3.2.1. Adult Stem Cells
    • 7.3.2.2. Embryonic Stem Cells
    • 7.3.2.3. Induced Pluripotent Stem Cells

8. Cell Expansion Market, by Application

• 8.1. Introduction
• 8.2. Cancer & Cell-Based Research
• 8.3. Regenerative Medicine & Stem Cell Research
• 8.4. Vaccine Production

9. Cell Expansion Market, by End-User

• 9.1. Introduction
• 9.2. Biotechnology & Biopharmaceutical Companies
• 9.3. Cell Banks
• 9.4. Research Institutes

10. Americas Cell Expansion Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Expansion Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Expansion Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. A Strategic Collaboration Between Thermo Fisher Scientific and Multiply Labs, Revolutionizing Cell Therapy Manufacturing through Automation
  • 13.3.2. luri Launches PluriCDMO for Advanced Cell Therapy Manufacturing Services
  • 13.3.3. Akadeum Life Sciences Advances Cell Therapy Research with Innovative Cell Isolation and Expansion Kits
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Bio-Techne Corporation
• 3. Celltainer Biotech B.V.
• 4. Corning Incorporated
• 5. Cytiva
• 6. Danaher Corporation
• 7. Eppendorf SE
• 8. G&G Technologies, Inc.
• 9. GE Healthcare
• 10. iXCells Biotechnologies
• 11. Lonza Group Ltd.
• 12. Merck KGaA
• 13. Miltenyi Biotec B.V. & Co. KG
• 14. Neuromics
• 15. NexImmune
• 16. Novartis AG
• 17. PromoCell GmbH
• 18. REPROCELL Inc.
• 19. Sartorius AG
• 20. Scinus Cell Expansion
• 21. Stemcell Technologies, Inc.
• 22. Takara Bio Inc.
• 23. Terumo BCT
• 24. TERUMO BCT, INC.
• 25. Thermo Fisher Scientific, Inc.